Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Membranous and cytoplasmic expression of epidermal growth factor receptor in metastatic pancreatic ductal adenocarcinoma.

Einama T, Ueda S, Tsuda H, Ogasawara K, Hatsuse K, Matsubara O, Todo S, Yamamoto J.

Exp Ther Med. 2012 Jun;3(6):931-936. Epub 2012 Mar 15.

2.

Potential crosstalk between insulin-like growth factor receptor type 1 and epidermal growth factor receptor in progression and metastasis of pancreatic cancer.

Ueda S, Hatsuse K, Tsuda H, Ogata S, Kawarabayashi N, Takigawa T, Einama T, Morita D, Fukatsu K, Sugiura Y, Matsubara O, Mochizuki H.

Mod Pathol. 2006 Jun;19(6):788-96.

3.

The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma.

Ueda S, Ogata S, Tsuda H, Kawarabayashi N, Kimura M, Sugiura Y, Tamai S, Matsubara O, Hatsuse K, Mochizuki H.

Pancreas. 2004 Jul;29(1):e1-8.

PMID:
15211117
4.

Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma.

Yeh TS, Tseng JH, Liu NJ, Chen TC, Jan YY, Chen MF.

Arch Surg. 2005 Dec;140(12):1184-90.

PMID:
16365240
5.

The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluation.

Cohen D, Lane B, Jin T, Magi-Galluzzi C, Finke J, Rini BI, Bukowski RM, Zhou M.

Clin Genitourin Cancer. 2007 Mar;5(4):264-70.

PMID:
17553206
6.

Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.

Valsecchi ME, McDonald M, Brody JR, Hyslop T, Freydin B, Yeo CJ, Solomides C, Peiper SC, Witkiewicz AK.

Cancer. 2012 Jul 15;118(14):3484-93. doi: 10.1002/cncr.26661. Epub 2011 Nov 15.

7.

Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.

Lee HJ, Xu X, Choe G, Chung DH, Seo JW, Lee JH, Lee CT, Jheon S, Sung SW, Chung JH.

Lung Cancer. 2010 Jun;68(3):375-82. doi: 10.1016/j.lungcan.2009.07.014. Epub 2009 Aug 26.

PMID:
19712993
8.

Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.

Onn A, Correa AM, Gilcrease M, Isobe T, Massarelli E, Bucana CD, O'Reilly MS, Hong WK, Fidler IJ, Putnam JB, Herbst RS.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):136-43.

9.

Expression of ERRP in normal and neoplastic pancreata and its relationship to clinicopathologic parameters in pancreatic adenocarcinoma.

Feng J, Adsay NV, Kruger M, Ellis KL, Nagothu K, Majumdar AP, Sarkar FH.

Pancreas. 2002 Nov;25(4):342-9.

PMID:
12409827
10.

High-sensitivity epidermal growth factor receptor immunostaining for colorectal carcinomas, compared with EGFR PharmDx™: a study of diagnostic accuracy.

Shiogama K, Wongsiri T, Mizutani Y, Inada K, Tsutsumi Y.

Int J Clin Exp Pathol. 2013;6(1):24-30. Epub 2012 Nov 20.

11.

Epidermal growth factor receptor expression in pancreatic carcinoma using tissue microarray technique.

Bloomston M, Bhardwaj A, Ellison EC, Frankel WL.

Dig Surg. 2006;23(1-2):74-9. Epub 2006 May 23.

PMID:
16717472
12.

Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid-tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation.

Tsuda H, Morita D, Kimura M, Shinto E, Ohtsuka Y, Matsubara O, Inazawa J, Tamaki K, Mochizuki H, Tamai S, Hiraide H.

Cancer Sci. 2005 Jan;96(1):48-53.

13.

Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.

Ozaki N, Ohmuraya M, Ida S, Hashimoto D, Ikuta Y, Chikamoto A, Hirota M, Baba H.

J Hepatobiliary Pancreat Sci. 2013 Aug;20(6):620-7. doi: 10.1007/s00534-012-0587-6.

PMID:
23475261
14.

Clinical relevance of epidermal growth factor receptor (EGFR) alterations in human pancreatic tumors.

Lozano-Leon A, Perez-Quintela BV, Iglesias-García J, Urisarri-Ruiz A, Lariño-Noia J, Abdulkader I, Varo E, Forteza J, Domínguez-Muñoz JE.

Oncol Rep. 2011 Aug;26(2):315-20. doi: 10.3892/or.2011.1309. Epub 2011 May 13.

PMID:
21573507
15.

Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma.

Xia M, Overman MJ, Rashid A, Chatterjee D, Wang H, Katz MH, Fleming JB, Lee JE, Varadhachary GR, Wolff RA, Wang H.

Hum Pathol. 2015 Sep;46(9):1315-22. doi: 10.1016/j.humpath.2015.05.012. Epub 2015 May 30.

PMID:
26165226
16.

EGFR expression and gene copy number in triple-negative breast carcinoma.

Gumuskaya B, Alper M, Hucumenoglu S, Altundag K, Uner A, Guler G.

Cancer Genet Cytogenet. 2010 Dec;203(2):222-9. doi: 10.1016/j.cancergencyto.2010.07.118.

PMID:
21156237
17.

Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas.

Papouchado B, Erickson LA, Rohlinger AL, Hobday TJ, Erlichman C, Ames MM, Lloyd RV.

Mod Pathol. 2005 Oct;18(10):1329-35.

18.

Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.

Rusch V, Baselga J, Cordon-Cardo C, Orazem J, Zaman M, Hoda S, McIntosh J, Kurie J, Dmitrovsky E.

Cancer Res. 1993 May 15;53(10 Suppl):2379-85.

20.

Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma.

Pu YS, Huang CY, Kuo YZ, Kang WY, Liu GY, Huang AM, Yu HJ, Lai MK, Huang SP, Wu WJ, Chiou SJ, Hour TC.

J Biomed Sci. 2009 Sep 12;16:82. doi: 10.1186/1423-0127-16-82.

Supplemental Content

Support Center